US FTC says separate trials in PBM antitrust case would be 'wasteful'
MLex Summary: The US Federal Trade Commission opposed pharmacy benefit managers’ request for separate hearings in an administrative lawsuit alleging anticompetitive conduct that pressured drugmakers to hike list prices of insulin to...To view the full article, register now.
Already a subscriber? Click here to view full article